SYRINGE

• Main Authors: PICCI MARIE, BUETTGEN HEINRICH MARTIN, BRYANT ANDREW MARK, SIGG JUERGEN, ROYER CHRISTOPHE
• Format: Patent
• Language: English; Korean
• Published: 18.03.2020
• Subjects: BANDAGES, DRESSINGS OR ABSORBENT PADS; DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; FILTERS IMPLANTABLE INTO BLOOD VESSELS; FIRST-AID KITS; FOMENTATION; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROSTHESES; TREATMENT OR PROTECTION OF EYES OR EARS

본 발명은 시린지, 특히 눈에의 주입에 적합한 시린지와 같은 저용량 시린지에 관한 것이다. The syringe (1) has a stopper arranged within a body (2) such that a front surface of the stopper and the body define a variable volume chamber from which a fluid is expelled though an outlet of the body, and a backstop (6) including two finger projections. A plunger (4) comprises a plunger contact surface to contact the stopper such that the plunger forces the stopper towards an outlet end. The syringe is filled with a vascular endothelial growth factor (VEGF) antagonist fluid of about 0.15-0.175 ml containing a non-antibody VEGF antagonist aflibercept at a concentration of 40 mg/ml. The syringe comprises a syringe barrel filled with silicone oil of 100 microgram.